Product Information

SELZENTRY 150 MG TABLET is a brand product labeled by ViiV Healthcare Company, priced at $28.0158 per EA under NDC 49702022318. Its NADAC has been published 648 times since Nov 28, 2013.

The High Outlier badge above means this manufacturer's average price in the maraviroc market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

SELZENTRY 150 MG TABLET

maraviroc
$28.0158per EA
High Outlier

Strength

150 mg/1

NDC

49702022318

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

MARAVIROC

Approval Type

New Drug (NDA)

FDA Application

NDA022128

On Market Since

5/16/2011

Pharmacological Classes

CCR5 Co-receptor Antagonist
Chemokine Co-receptor 5 Antagonists

Price Statistics

The NADAC for SELZENTRY 150 MG TABLET has been published 648 times since Nov 28, 2013, and over the history we have for it it has risen 60.5%. The table below summarizes its recorded NADAC range and movement.

Current price$28.0158 per EA
All-time high$28.0158 (Jun 24, 2026)
All-time low$17.3433 (Jan 22, 2014)
52-week high$28.0158
52-week low$27.8975
Median price$25.0585
Average price$24.2017
Largest weekly change+7.9% (Feb 8, 2017)
Weeks tracked648
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

0.0%

3M

+0.1%

6M

+0.3%

1Y

+0.3%

3Y

+0.2%

5Y

+11.4%

All

+60.5%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the maraviroc market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of SELZENTRY 150 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for SELZENTRY 150 MG TABLET, manufactured by ViiV Healthcare Company, is $28.0158 per EA (NDC 49702022318), effective Jun 24, 2026.

How has the price of SELZENTRY 150 MG TABLET changed over time?

Over the history we have for it, the NADAC for SELZENTRY 150 MG TABLET has risen 60.5%. It has been tracked across 648 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for SELZENTRY 150 MG TABLET?

Since Nov 28, 2013, the NADAC for SELZENTRY 150 MG TABLET has ranged from a low of $17.3433 (Jan 22, 2014) to a high of $28.0158 (Jun 24, 2026), with a median of $25.0585 per EA.

Are there cheaper alternatives to SELZENTRY 150 MG TABLET?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of SELZENTRY 150 MG TABLET, so no direct lower-cost alternative is listed.

Who manufactures SELZENTRY 150 MG TABLET?

SELZENTRY 150 MG TABLET (NDC 49702022318) is labeled by ViiV Healthcare Company, and CMS classifies it as a brand product.

Related Drugs

Same classification

No related drugs found.